Meet Revo, our newest Digital SPR platform, engineered to deliver premium performance at a revolutionary price. Get high-end SPR clarity with industry-leading noise and drift, enabling tough samples, challenging applications, & deeper mechanistic insights
https://t.co/MBbd2uAQUp
With MSF (modulated scanning fluorimetry), SUPR-DSF measures both melting temperature (Tm) and non-reversibility onset (Tnr), revealing when structural changes become irreversible, often before aggregation is detectable.
Explore MSF on SUPR-DSF ➡️ https://t.co/tquz32qps1
FastHDX brings hydrogen deuterium exchange into the millisecond timescale, enabling researchers to observe rapid structural dynamics that shape protein function and interaction.
Learn more here ➡️ https://t.co/eySYwohhaF
It’s not just a new instrument. It’s a powerful, intuitive, science-first platform designed to make real SPR data possible for more researchers than ever before.
Be part of the movement at https://t.co/MBbd2uAQUp
No clogged fluidics. No 100 µL sample sacrifices. No steep learning curve. Just scalable SPR that fits your research needs. Join the revolution.
https://t.co/MBbd2uAQUp
Traditional SPR and BLI, step aside. A new label-free platform is coming, and it challenges everything you expect from the category – cost, complexity, sample requirements, and who can actually access high-quality kinetics.
https://t.co/MBbd2uAj4R
With Alto it's all treats - no tricks 🎃 Get frighteningly high-quality binding affinity and interaction data with #digitalSPR
Happy Halloween from all of us at Nicoya! BOO! 👻 👻
https://t.co/usEtj9hMAz
Obtain high-quality data and publish with confidence using OpenSPR. For a fraction of the cost of existing solutions, OpenSPR provides real-time, label-free analysis of affinity and kinetics data for a wide range of biomolecular applications.
Learn more👉https://t.co/hjQTZeGJF5
In our latest tech note, learn how Alto can be leveraged to evaluate AAV binding interactions using Anti-AAV capture surfaces.
Read it here ➡️ https://t.co/eU2z2b5SQV
OpenSPR played a crucial role in a recent HIV vaccine study, revealing key binding insights into a novel immunogen that targets both arms of VRC01-class antibodies.
Read the full article: https://t.co/Q44CAwWCPv
#HIV#Immunology
Join us on May 21st for our #webinar, “Throughput vs. ease of use: Don't make compromises in #antibody screening and characterization,” with Michael Piazza, PhD, Qinan Zhuang and Han Su, PhD.
Register today 👉 https://t.co/ysqiOeiG0G
Introducing Nicosystem 2.5.2 for #Alto#DigtalSPR! 🚀 With this update, we continue our mission to help scientists succeed by delivering reliable, high-quality #SPR data.
🔗 Visit our website to learn more: https://t.co/cYWiHeexIu
Don’t miss your chance to register for our live #webinar, “Throughput vs. ease of use: Don't make compromises in #antibody screening and characterization”! Join us tomorrow at 1 PM EDT/10 AM PDT to hear from Dr. Michael Piazza.
Register now 👉 https://t.co/vZ2stlMtVO
#biotech
Join us on March 27th for our #webinar, “Throughput vs. ease of use: Don't make compromises in #antibody screening and characterization,” with Dr. Michael Piazza, Associate VP of Applications Development.
Register now 👉 https://t.co/vZ2stlMtVO
In collaboration with @Proteintech, we're excited to introduce the human/rabbit IgG VHH capture kit designed to simplify your label-free analysis.
Learn more 👉 https://t.co/FtoEaNMd2y
Join us for our #webinar, “Throughput vs. ease of use: Don't make compromises in #antibody screening and characterization,” with Dr. Michael Piazza.
📆 March 27, 2025
🕐 10 AM PDT / 1 PM EDT
📍 Online
Register now 👉 https://t.co/vZ2stlMtVO
We’ll be at @OGConferences' #NextGenBiomed next week! Visit booth 91 to chat with our very own Anja Mathiesen and Merrow Scientific’s Sam Nunez. See #Alto#DigitalSPR in action and discover how it can accelerate your #biologics#research!
See you there! 👋
Join us for An Affinity Affair: SSF on Feb 18th! 🎉 Explore the latest in #biosensor tech, see live demos of #Alto#DigitalSPR, and hear from industry leaders Sriram Kumaraswamy, PhD, and Kerry Oliver, PhD.
Register today! 👇
https://t.co/eANiOrcxMl
#AffinityAffairSSF#biotech
Explore how #Alto is accelerating #biotherapeutics development with label-free #biosensor technology!
In our latest app note, we show how #Alto#DigitalSPR streamlines antibody analysis to various classes of FcγRs with unmatched efficiency.
Read it here: https://t.co/b3YuZnYegG
Join us for an Affinity Affair SSF! In collaboration with @biotechne, we invite you to an unforgettable evening of #networking & discovery as we explore the future of #biosensor technology & #drugdiscovery.
📆Feb 18
📍The Lighthouse
Register now 👇
https://t.co/eANiOrcxMl